Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47.9M
-
Number of holders
-
190
-
Total 13F shares, excl. options
-
55.5M
-
Shares change
-
+809K
-
Total reported value, excl. options
-
$2.19B
-
Value change
-
+$31.1M
-
Number of buys
-
119
-
Number of sells
-
-68
-
Price
-
$39.49
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q2 2017
208 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q2 2017.
HAEMONETICS CORP - Common Stock (HAE) has 190 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.5M shares
.
Largest 10 shareholders include BlackRock Inc. (6.26M shares), VANGUARD GROUP INC (4.74M shares), WELLINGTON MANAGEMENT GROUP LLP (4.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.23M shares), WELLS FARGO & COMPANY/MN (2.79M shares), FULLER & THALER ASSET MANAGEMENT, INC. (2.22M shares), VICTORY CAPITAL MANAGEMENT INC (2.03M shares), Neuberger Berman Group LLC (1.86M shares), HealthCor Management, L.P. (1.85M shares), and DIMENSIONAL FUND ADVISORS LP (1.74M shares).
This table shows the top 190 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.